Europe Drug Regulator’s Advising Panel Recommends Approval Of Novo Nordisk’s Australia-Approved Hemophilia Drug
Europe Drug Regulator's Advising Panel Recommends Approval Of Novo Nordisk's Australia-Approved Hemophilia DrugOn Friday, Novo Nordisk A/S (NYSE:NVO) said that...